MedTrace Logo

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

NCT00898079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2545

Last updated 2018-07-19

No results posted yet for this study

Summary

This study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer. Collecting and storing samples of tumor tissue, blood, and bone marrow from patients with cancer to study in the laboratory may help the study of cancer in the future.

Conditions

  • Acute Undifferentiated Leukemia
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Childhood Acute Lymphoblastic Leukemia
  • Childhood Acute Myeloid Leukemia
  • Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Childhood Solid Neoplasm
  • Chronic Lymphocytic Leukemia
  • Hairy Cell Leukemia
  • Juvenile Myelomonocytic Leukemia
  • Mast Cell Leukemia
  • Neoplasm of Uncertain Malignant Potential
  • Prolymphocytic Leukemia
  • Secondary Acute Myeloid Leukemia
  • T-Cell Large Granular Lymphocyte Leukemia

Interventions

OTHER

Cytology Specimen Collection Procedure

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Nilsa Ramirez · Children's Oncology Group

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-13
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States
  • Australia
  • Canada
  • New Zealand
  • Puerto Rico
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898079 on ClinicalTrials.gov